| scholarly article | Q13442814 |
| P50 | author | Birgit Reipert | Q104536448 |
| Hans-Peter Schwarz | Q108290186 | ||
| P2093 | author name string | Friedrich Scheiflinger | |
| Maria Schuster | |||
| Mantas Malisauskas | |||
| Gerhard Antoine | |||
| Markus Weiller | |||
| Sabine Unterthurner | |||
| Maurus de la Rosa | |||
| Christine Lenk | |||
| P2860 | cites work | Treatment of congenital factor VII deficiency with a new concentrate | Q67399902 |
| Prevalence of inhibitors in a population of 3435 hemophilia patients in France. French Hemophilia Study Group | Q68024148 | ||
| Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody | Q69663611 | ||
| No simple solution for making transgenic mice | Q69777598 | ||
| The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model | Q72643685 | ||
| Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII | Q74207828 | ||
| Life-threatening bleeding in a case of autoantibody-induced factor VII deficiency | Q74593808 | ||
| Generation of genetically-altered mice producing very low levels of coagulation factorVII | Q81438677 | ||
| Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation | Q22254871 | ||
| Heterologous introns can enhance expression of transgenes in mice | Q24561537 | ||
| Lipopolysaccharide endotoxins | Q24650970 | ||
| Regulatory T cells exert checks and balances on self tolerance and autoimmunity | Q28267935 | ||
| Toll-like receptor control of the adaptive immune responses | Q29547305 | ||
| Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b. | Q30351459 | ||
| Rat growth hormone gene introns stimulate nucleosome alignment in vitro and in transgenic mice | Q34002397 | ||
| Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines | Q34077417 | ||
| Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice | Q34626392 | ||
| Inhibitors in congenital coagulation disorders | Q35937076 | ||
| Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue | Q36404280 | ||
| Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease | Q37221573 | ||
| Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog. | Q37586365 | ||
| Checkpoints in lymphocyte development and autoimmune disease | Q37657051 | ||
| Mechanisms maintaining peripheral tolerance. | Q37657055 | ||
| Localisation and trafficking of Toll-like receptors: an important mode of regulation. | Q37671100 | ||
| Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteins | Q40981986 | ||
| Expression of self-antigen in the thymus: a little goes a long way. | Q42090814 | ||
| A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study | Q42598903 | ||
| Hepatocyte-specific expression of Cre recombinase | Q43604415 | ||
| Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity | Q43996020 | ||
| Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia | Q44355510 | ||
| Transgenic mice as a model to test the immunogenicity of proteins altered by site-specific mutagenesis | Q44969813 | ||
| Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors | Q45855862 | ||
| A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation | Q45858938 | ||
| Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model | Q45871273 | ||
| The LPS receptor (CD14) links innate immunity with Alzheimer's disease | Q47405789 | ||
| Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. | Q47848482 | ||
| Amyloid beta peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells | Q48093117 | ||
| Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. | Q48176320 | ||
| Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution. | Q50652323 | ||
| A mouse model for monitoring calpain activity under physiological and pathological conditions. | Q51487311 | ||
| Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. | Q52936537 | ||
| MyD88 signaling controls autoimmune myocarditis induction. | Q53641484 | ||
| Development of a transgenic mouse model immune tolerant for human interferon Beta. | Q54484718 | ||
| A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals | Q58895670 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 2855-2867 | |
| P577 | publication date | 2013-06-18 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Development of a transgenic mouse model with immune tolerance for human coagulation factor VIIa | |
| P478 | volume | 30 |
| Q90836400 | Immunogenicity of Protein Pharmaceuticals | cites work | P2860 |
Search more.